Alison Narayan
Alison Narayan is a Research Assistant Professor at the University of Michigan. She received her bachelor’s degree in chemistry from the University of Michigan and her doctorate in organic chemistry from the University of California, Berkeley. She completed postdoctoral studies in chemistry at the University of Michigan in the lab of David Sherman, faculty member of the University of Michigan Life Sciences Institute. Alison, also known as the Enzyme Mastermind, was a part of the Talented 12 class of 2016. Her research focuses on using biocatalysts to develop methods to synthesize biologically active molecules.
Hosea Nelson
Hosea Nelson is an Assistant Professor of Chemistry at the University of California, Los Angeles. He received his bachelor’s degree in chemistry from the University of California, Berkeley and his doctorate in chemistry from California Institute of Technology. After postdoctoral training at University of California, Berkeley, he joined the UCLA faculty in 2015. Hosea, also known as the Bioactives Builder, was a member of the Talented 12 class of 2015. His research focuses on reaction development and target-driven organic synthesis.
Renee Frontiera
Renee Frontiera is an Associate Professor of Chemistry and McKnight Land-Grant Professor at the University of Minnesota. She received her bachelor’s degree from Carleton College and her doctorate from the University of California, Berkeley. After some postdoctoral training at Northwestern University, Renee joined the UMN faculty. Renee, also known as the Spectroscopy Savant, was a member of the Talented 12 class of 2017. Her research focuses on protein biophysics, alternative energy sources, and nanotechnology.
Lisa Jarvis
Lisa Jarvis is a Senior Correspondent at C&EN, the news magazine of the American Chemical Society, where she leads coverage of the pharmaceutical industry. After studying chemistry at Bard College and Northwestern University, Lisa shifted to a career in science journalism. Lisa has more than 15 years of experience covering the science and business of developing drugs, and her work has been recognized as a finalist for the National Academies Communication Award.